Breaking News

Almac Announces £80M Expansion at Global Headquarters

Includes an extension to current scales of production for products involving potent and highly potent APIs.

The Almac Group unveiled an £80 million investment program to build new extensive manufacturing, production, and diagnostic lab facilities at its global headquarters in Craigavon, Northern Ireland.  The expansion, which is part of the global investment program announced in 2022, will significantly grow operations for two of the group’s business units, Almac Pharma Services and Almac Diagnostic Services.  Almac Pharma Services supports the development and commercialization of new treatment ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters